Literature DB >> 11527850

Seizure disorders: Part 2. Treatment.

S Kammerman1, L Wasserman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11527850      PMCID： PMC1071539          DOI： 10.1136/ewjm.175.3.184

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  11 in total

1.  Reassessment: vagus nerve stimulation for epilepsy: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  R S Fisher; A Handforth
Journal:  Neurology       Date:  1999-09-11       Impact factor: 9.910

2.  Recommended guidelines for diagnosis and treatment in specialized epilepsy centers.

Authors: 
Journal:  Epilepsia       Date:  1990       Impact factor: 5.864

3.  Practice parameter: a guideline for discontinuing antiepileptic drugs in seizure-free patients--summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors: 
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

Review 4.  Surgery for seizures.

Authors:  J Engel
Journal:  N Engl J Med       Date:  1996-03-07       Impact factor: 91.245

Review 5.  Antiepileptic drugs.

Authors:  M J Brodie; M A Dichter
Journal:  N Engl J Med       Date:  1996-01-18       Impact factor: 91.245

6.  Pregnancy and epilepsy: a retrospective study of 151 pregnancies.

Authors:  A Sabers; B aRogvi-Hansen; M Dam; W Fischer-Rasmussen; L Gram; M Hansen; A Møller; H Winkel
Journal:  Acta Neurol Scand       Date:  1998-03       Impact factor: 3.209

7.  A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group.

Authors: 
Journal:  Neurology       Date:  1995-02       Impact factor: 9.910

8.  If a well-stabilized epileptic patient has a subtherapeutic antiepileptic drug level, should the dose be increased? A randomized prospective study.

Authors:  E Woo; Y M Chan; Y L Yu; Y W Chan; C Y Huang
Journal:  Epilepsia       Date:  1988 Mar-Apr       Impact factor: 5.864

9.  Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures.

Authors:  R H Mattson; J A Cramer; J F Collins; D B Smith; A V Delgado-Escueta; T R Browne; P D Williamson; D M Treiman; J O McNamara; C B McCutchen
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

Review 10.  Optimizing long-term patient compliance.

Authors:  J A Cramer
Journal:  Neurology       Date:  1995-02       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.